IMRN Intrinsic Valuation and Fundamental Analysis - Immuron Ltd

I	Immuron Ltd NASDAQ:IMRN	AU
R	Royal Caribbean Cruises Ltd F:RC8	US
	East Pipes Integrated Company for Industry LJSC SAU:1321	SA
C	CECONOMY AG F:CEC	DE
	Huatai Securities Co Ltd F:206H	CN
	SRP Groupe SA PAR:SRP	FR
A	Adobe Inc BMV:ADBE	US
T	Toray Industries Inc OTC:TRYIY	JP
	Intred SpA MIL:ITD	IT
C	China Gas Holdings Ltd XHAM:EBZ	HK
	Indofood CBP Sukses Makmur Tbk PT OTC:PNDFF	ID
	Cyberecord Inc OTC:CYRD	US
F	Fuji Electric Co Ltd DUS:FJE	JP

Intrinsic Value

IMRN doesn't have a meaningful market cap.

Is IMRN undervalued or overvalued?

See the intrinsic value estimate for Immuron Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

IMRN Intrinsic Value

Unlock

Today vs. history

See how today’s valuation compares with IMRN’s past valuations and how the stock performed after similar periods.

See what happened next Free account required

Track Buy Zone

20% below Intrinsic Value

Get notified when the price drops into your buy zone

Intrinsic Value Locked

Margin of Safety 20% Locked

Current Price $0.93

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Fundamental Analysis

What Immuron Does

Biotechnology Health Care

Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. The company operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada.

Headquarters: Australia AU
Employees: 7
IPO date: Apr 30, 1999